LA
ABBV icon

LM Advisors’s AbbVie ABBV Stock Holding History

LM Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Buy
+1,190
New +$256K 0.03% 189
2025
Q2 		– Sell
-2,170
Closed -$455K – 186
2025
Q1 		$455K Buy
+2,170
New +$422K 0.08% 163
2024
Q1 		– Sell
-677
Closed -$105K – 218
2023
Q4 		$105K Buy
+677
New +$98.7K 0.02% 251

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LM Advisors's ABBV Position: Q2 2026 in Review

LM Advisors opened a new position in AbbVie (ABBV) in Q2 2026: 1,190 shares worth $300K. The stake represents 0.03% of the portfolio and ranks #189 among its holdings. This is a return to the name: LM Advisors previously reported a position in ABBV as recently as Q1 2025.

LM Advisors first reported a position in ABBV in Q4 2023 and has held it in 3 quarters since. The position peaked at $455K in Q1 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • LM Advisors held 1,190 shares of AbbVie worth $300K as of Q2 2026.
  • AbbVie was a new LM Advisors position in Q2 2026.
  • AbbVie made up 0.03% of LM Advisors's portfolio in Q2 2026, its #189 holding.
  • LM Advisors first reported a position in AbbVie in Q4 2023 and has held it in 3 quarters since.
  • LM Advisors's AbbVie position peaked at $455K in Q1 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LM Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.